IP Library Patent Application 15567250
Patent Application
App. No. 15/567,250

DELIVERING NON-PATHOGENIC, INTESTINALLY BENEFICIAL BACTERIA TO A PATIENT HAVING A FEEDING TUBE

Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US None
App. No.
15/567,250
Abstract

Devices and methods for delivering non-pathogenic, intestinally beneficial bacteria to a patient having a feeding tube. Examples of non-pathogenic, intestinally beneficial bacteria that could be used include Bifidobacterium species and Lactobacillus species. In one embodiment, the bacteria is contained in a bacteria infusion device that comprises: (a) an internal chamber; (b) an outlet in communication with the internal chamber; and (c) the non-pathogenic, intestinally beneficial bacteria contained in the internal chamber. Another embodiment is a feeding tube comprising a flexible tubing and coating on the outer surface of the flexible tubing. The coating comprises an antimicrobial agent. Also disclosed are methods of administering a non-pathogenic, intestinally beneficial bacteria to a patient.

Claims (67)

1 . A bacteria infusion device comprising:

an internal chamber;

an outlet in communication with the internal chamber; and

a non-pathogenic, intestinally beneficial bacteria contained in the internal chamber.

2 . The device of claim 1 , wherein the bacteria is a Bifidobacterium species.

3 . The device of claim 1 or 2 , wherein the bacteria is B. breve, B. longum , or B. pseudocatenulatum.

4 . The device of any one of claims 1 - 3 , wherein the bacteria is B. longum of subspecies infantis.

5 . The device of claim 1 , wherein the bacteria is a Lactobacillus species

6 . The device of claim 1 or 5 , wherein the bacteria is L. plantarum, L. pentosus, L. sahvarius, L. crispatus, L. sakei, L. antri , or L. coleohominis.

7 . The device of any one of claims 1 - 6 , wherein the amount of bacteria is 0.1 billion to 100 billion live colony forming units.

8 . The device of any one of claims 1 - 7 , further comprising a bacteria-preserving agent mixed with the bacteria.

9 . The device of claim 8 , wherein the bacteria-preserving agent is trehalose, sorbitol, albumin, polyethylene glycol, polyvinylpyrrolidone, milk fractions, dimethyl sulfoxide, or glycerol.

10 . The device of any one of claims 1 - 9 , wherein the bacteria is in a solid form.

11 . The device of any one of claims 1 - 9 , wherein the bacteria is in a liquid medium.

12 . The device of claim 11 , wherein the volume of liquid medium is in the range of 0.3 ml to 5 ml.

13 . The device of claim 12 , wherein the volume of liquid medium is about 0.5 ml, about 1 ml, about 1.5 ml, about 2 ml, about 2.5 ml, about 3 ml, about 3.5 ml, about 4 ml, about 4.5 ml, or about 5 ml.

14 . The device of any one of claims 1 - 13 , wherein the device further comprises a liquid medium which comprises a nutritional ingredient.

15 . The device of claim 14 , wherein the nutritional ingredient is an oil, a mammalian milk, or an artificial nutritional formulation.

16 . The device of claim 15 , wherein the oil is a triglyceride oil.

17 . The device of claim 16 , wherein the oil is a medium chain triglyceride oil.

18 . The device of claim 15 wherein the nutritional formulation comprises bacterial supernatant.

19 . The device of any one of claims 1 - 18 , wherein the bacteria has surface structures that internalize milk glycans or derivative monomers of milk glycans.

20 . The device of any one of claims 1 - 19 , further comprising an outlet fitting for coupling the outlet to a feeding tube.

21 . The device of any one of claims 1 - 20 , further comprising an inlet and an inlet fitting for coupling the inlet to an enteral feed source.

22 . The device of claim 21 , wherein the inlet fitting, outlet fitting, or both are standardized medical connection fittings.

23 . The device of claim 22 , wherein the medical connection fitting comprises a threaded lock.

24 . A feeding tube comprising:

a flexible tubing;

a feed port on the flexible tubing; and

a bacteria infusion device of any one of claims 1 - 23 coupled to the feed port.

25 . The feeding tube of claim 24 , wherein the feeding tube is a naso-gastric feeding tube.

26 . A feeding tube comprising:

a flexible tubing comprising an outer surface; and

a coating on the outer surface of the flexible tubing, the coating comprising an antimicrobial agent.

27 . The feeding tube of claim 26 , wherein the feeding tube is a naso-gastric feeding tube.

28 . The feeding tube of claim 26 or 27 , wherein the antimicrobial agent is a protein.

29 . The feeding tube of any one of claims 26 - 28 , wherein antimicrobial agent is a milk protein.

30 . The feeding tube of any one of claims 26 - 29 , wherein the antimicrobial agent is lactoferrin or lysozyme.

31 . The feeding tube of any one of claims 26 - 30 , wherein the antimicrobial agent is a naturally-occurring compound.

32 . The feeding tube of claim 31 , wherein the antimicrobial agent is allicin, catechin, citricidal, cinnamaldehyde, or carvacrol.

33 . The feeding tube of claim 26 or 27 , wherein the antimicrobial agent is a synthetic compound.

34 . The feeding tube of any one of claims 26 - 33 , wherein the antimicrobial agent is covalently immobilized to the outer surface of the flexible tubing.

35 . The feeding tube of any one of claims 26 - 34 , further comprising a bacteria infusion device of any one of claims 1 - 23 .

36 . A kit comprising:

a feeding tube, optionally according to any one of claims 24 - 35 ; and

a bacteria infusion device of any one of claims 1 - 23 .

37 . The kit of claim 36 , wherein the bacteria infusion device further comprises an outlet fitting for coupling the outlet to the feeding tube.

38 . A method of assembling the kit of claim 36 or 37 , wherein the bacteria infusion device has a proximal end and a distal end, the method comprising coupling the distal end to the feeding tube.

39 . The method of claim 38 , further comprising coupling the proximal end to an enteral feed source.

40 . A method of administering a non-pathogenic, intestinally beneficial bacteria to a patient having a feeding tube inserted into the gastrointestinal tract, the method comprising infusing a non-pathogenic, intestinally beneficial bacteria into the patient's gastrointestinal tract.

41 . The method of claim 40 , wherein the infusion of bacteria is performed through the feeding tube.

42 . The method of claim 40 or 41 , wherein the bacteria is in a liquid medium.

43 . The method of claim 42 , wherein the volume of liquid medium is in the range of 0.3 ml to 5 ml.

44 . The method of any one of claims 40 - 43 , further comprising, prior to use, storing the bacteria at a temperature that is below 20° C.

45 . The method of any one of claims 40 - 44 , further comprising repeating the step of infusing the bacteria into the gastrointestinal tract.

46 . The method of claim 45 , wherein continued infusion of bacteria is for the duration that enteral feeding is required.

47 . The method of claim 45 or 46 , wherein the repeated infusion is performed within 12 hours to 72 hours after the initial infusion.

48 . The method of any one of claims 40 - 47 , wherein the bacteria is infused simultaneously with infusion of an enteral feed.

49 . The method of any one of claims 40 - 48 , wherein the enteral feed comprises an oligosaccharide found in mammalian milk.

50 . The method of any one of claims 40 - 49 , further comprising coupling a bacteria infusion device of any one of claims 1 - 23 to the feeding tube, and wherein the bacteria and/or its supernatant is infused out from the internal chamber through the outlet.

51 . The method of claim 50 , further comprising coupling an enteral feed source to the bacteria infusion device.

52 . The method of claim 51 , further comprising infusing the enteral feed source through the bacteria infusion device and into the feeding tube.

53 . The method of claim 51 or 52 , further comprising detaching the bacteria infusion device after the enteral feed infusion is complete.

54 . The method of any one of claims 40 - 53 , wherein the feeding tube comprises:

an outer surface; and

a coating on the outer surface of the feeding tube, the coating comprising an antibacterial agent.

55 . The method of any one of claims 40 - 54 , wherein the patient is a preterm infant.

Assignments (2)
CHANGE OF NAME Recorded Nov 10, 2022
From: EVOLVE BIOSYSTEMS INC.
To: INFINANT HEALTH, INC
Reel/Frame 061914/0408 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 17, 2017
From: KYLE, DAVID; MILLS, DAVID; FREEMAN-SHARKEY, SAMARA
To: EVOLVE BIOSYSTEMS INC.
Reel/Frame 043885/0975 →